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Structure of a Complex between E. coli
DNA Topoisomerase I and Single-Stranded DNA
steps (illustrated and described in Figure 1). Each of
these putative steps represents a different conforma-
tion, most likely unstable and transient, of the protein
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Northwestern University and/or the DNA. A complete understanding of the cata-
lytic cycle requires structural information on many, if2205 Tech Drive
Evanston, Illinois 60208 not all, of these conformational states. In particular,
complexes of type IA topoisomerases with DNA repre-
senting different complexes along the catalytic pathway
will help elucidate the way these protein recognize,
Summary
cleave, and change the topology of DNA molecules.
Previous structural studies of complexes of E. coli
In order to gain insights into the mechanism of ssDNA
DNA topoisomerase I with nucleotides (Feinberg et al.,
binding and recognition by Escherichia coli DNA topo-
1999a) defined four nucleotide binding sites within the
isomerase I, the structure of the 67 kDa N-terminal
protein (Figure 2) and suggested that an invariant histi-
fragment of topoisomerase I was solved in complex
dine, His365, may control the location and flexibility of
with ssDNA. The structure reveals a new conforma-
a disordered loop formed by amino acids 356–364 and
tional stage in the multistep catalytic cycle of type IA
located adjacent to the active site and near one of the
topoisomerases. In the structure, the ssDNA binding
nucleotide binding sites (Feinberg et al., 1999a). Bio-
groove leading to the active site is occupied, but the
chemical studies confirmed the importance of His365
active site is not fully formed. Large conformational
and suggested a role for this conserved residue in
changes are not seen; instead, a single helix parallel
ssDNA binding and in catalysis (Perry and Mondrago´n,
to the ssDNA binding groove shifts to clamp the
2002). Recently, the structure of a complex between a
ssDNA. The structure helps clarify the temporal se-
catalytically inactive mutant of E. coli DNA topoisomer-
quence of conformational events, starting from an ini-
ase III—where the active site tyrosine was replaced with
tial empty enzyme and proceeding to a ssDNA-occu-
a phenylalanine (Y328F)—and an 8-base oligonucleotide
pied and catalytically competent active site.
showed that domain III rotates away from domains I and
IV by 20 in order for the protein to accommodate
ssDNA (Changela et al., 2001). Additionally, in the topo-Introduction
isomerase III/ssDNA complex, domain IV undergoes
substantial internal reorganization. As an inactive en-DNA topoisomerases are the enzymes responsible for
maintaining the topological state of cellular DNA. These zyme, the complex of topoisomerase III and ssDNA is
most likely a precleavage or postligation complex (corre-ubiquitous enzymes are involved in essential cellular
processes, including transcription, chromosome con- sponding to states c* and f* in Figure 1). Given that aside
from the apo enzyme structures only a single conforma-densation and segregation, and recombination (Cham-
poux, 2001; Wang, 1996). The structure of the 67 kDa tion in the multistep process has been determined, it is
important to elucidate the structure of more conforma-N-terminal fragment of E. coli DNA topoisomerase I, a
paradigm for all type IA topoisomerases, was solved tions along the catalytic pathway. Here we report the
structure of a topoisomerase I/ssDNA complex. Thepreviously (Lima et al., 1994) and shows that the enzyme
is composed of four domains (I–IV) encircling a central structure reveals a new conformational state putatively
situated between the empty and the catalytically compe-hole. Domain I, also known as a TOPRIM domain (Ara-
vind et al., 1998), has a Rossmann fold topology (Rao tent enzyme (between states a* and b** or between h**
and i* in Figure 1). The structure helps clarify the se-and Rossmann, 1973) and together with domain III forms
the active site of the enzyme. Leading to the active site quence of events that lead from an empty and closed
enzyme to a fully formed and occupied active site withis a ssDNA binding groove formed by residues from
domains I and IV. All topoisomerases cleave DNA by ssDNA located in the ssDNA binding groove.
forming a transient phosphotyrosine bond. In type IA
topoisomerases, the active site tyrosine resides in do-
Resultsmain III (Tyr319 in E. coli topoisomerase I) and is buried
in the interface formed by domains I and III in a region
Three-Dimensional Structure of the Complexcomposed by conserved and highly conserved amino
between the 67 kDa N-Terminal Domainacids.
of E. coli Topoisomerase I and ssDNAThe proposed catalytic cycle for all type IA topoisom-
The complex between E. coli topoisomerase III anderases (Changela et al., 2001; Li et al., 2001; Lima et al.,
ssDNA suggests that the optimal size for a stable com-1994; Mondrago´n and DiGate, 1999) involves multiple
plex between a type IA topoisomerase and ssDNA is
around 8 bases (Changela et al., 2001). Type IA enzymes
*Correspondence: a-mondragon@northwestern.edu
do not display a strong sequence preference, and there1Present address: Department of Biochemistry and Biophysics,
is no unique binding sequence for topoisomerase I;Howard Hughes Medical Institute, University of Pennsylvania School
of Medicine, Philadelphia, Pennsylvania 19104. hence, several different oligonucleotides with sequences
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Figure 1. Diagram Illustrating the Proposed Mechanism of DNA Relaxation Catalyzed by Type IA DNA Topoisomerases
The proposed mechanism of relaxation of supercoiled DNA by a type IA topoisomerase involves several different transient intermediates
involving conformational changes of both the enzyme (gray toroid with a yellow ssDNA binding region) and the DNA (red/blue molecule). The
green dot represents the presence of the transient, covalent phosphotyrosine bond between the enzyme and the ssDNA. Single asterisks
denote the conformational states where structural information was previously known, while double asterisks refer to the structures described
here.
(a) Enzyme and supercoiled DNA prior to catalysis. The enzyme is in the closed conformation as found in the apo structure of both E. coli
DNA topoisomerase I (Lima et al., 1994) and III (Mondrago´n and DiGate, 1999).
(b) The enzyme recognizes a ssDNA region and binds it in the DNA binding groove. This helps position the ssDNA for entry into the active
site.
(c) Further entrance of the ssDNA into the protein triggers a conformational change to create a catalytically competent active site, as observed
in the structure of the complex of topoisomerase III with ssDNA (Changela et al., 2001), and ssDNA cleavage occurs at the active site, via
formation of a covalent bond between the 5-phosphoryl and the hydroxyl of the active site tyrosine, whereas the 3 end of the DNA remains
noncovalently bound to the enzyme via the DNA binding groove.
(d) The enzyme opens, bridges the gap between the broken ends of the cleaved DNA, and allows passage of the other strand between the
separated ends and into the hole of the toroid.
(e) Enzyme-catalyzed strand passage of the second strand of DNA into the central hole of the enzyme. The nature of the conformational
change may be illustrated by the structure of the 30 kDa fragment of E. coli topoisomerase I (Feinberg et al., 1999b).
(f) Following strand passage, the enzyme closes, trapping the passing DNA strand inside the toroid. Once the gate is closed, the cleaved strand
is religated by the enzyme. The structure of the ssDNA/enzyme complex during religation is illustrated by the structure of the topoisomerase III
complex (Changela et al., 2001).
(g) The cycle is completed by the enzyme opening to release both the religated strand and the one that was passed through the gap.
(h) The enzyme returns to a closed conformation after the ssDNA in the hole of the toroid has been released, but the religated strand remains
bound to the DNA binding groove, resulting in a partial exit of the DNA.
(i) Upon complete release of the DNA, the enzyme returns to its empty, closed conformation. During the cycle, one DNA strand has passed
through the other to change the topology of the DNA and alter the linking number by 1. The reaction always proceeds toward relaxation of
the DNA.
based on previously identified preferred cleavage se- crystals showed a single band of ssDNA that comigrated
with molecular weight standards between 7 and 8 basesquences (Dean et al., 1983; Zhang et al., 1996) were
designed and used for cocrystallization experiments (data not shown), suggesting that the oligonucleotide
was cleaved in the crystallization drop. Although the lowwith the 67 kDa N-terminal fragment of E. coli topoisom-
erase I (T67), both with a catalytically inactive Phe mu- pH of the crystallization conditions may inhibit oligonu-
cleotide cleavage, as previous experiments show thattant (T67-Y319F) and with a high DNA binding affinity
mutant (T67-H365R). However, only crystals of a com- E. coli topoisomerase I is unable to relax supercoiled
DNA or cleave oligonucleotides at a pH below 6 (Perryplex between the H365R mutant and an 11-base oligo-
mer, 5-ACTTC↓GGG↓ATG-3 (↓ indicates a possible site and Mondrago´n, 2002), the reaction could still occur at
an extremely low rate. Therefore, in the extended periodof topoisomerase I cleavage), were produced (hereafter
referred to as T67-H365R/11). Gel electrophoresis of needed for crystallization, hundreds of times longer than
the timescale used for relaxation and cleavage assays,radioactively labeled oligonucleotides from dissolved
E. coli Topoisomerase I/ssDNA Complex
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Figure 2. The Structure of the T67-H365R/11-mer Complex
Domains I, II, III, and IV of topoisomerase I are colored blue, purple, red, and green, respectively. The minor conformation of the shifted 
helix between residues 499 and 507 (helix O) is depicted in hot pink, the ssDNA is depicted in yellow, and the 5-TMP at site I is colored gray.
Top: The overall structure of the T67-H365R/11 complex. The two views are orthogonal to each other. The locations of the nucleotide binding
sites II, III, and V are labeled. When the 67 kDa fragment is complexed with mono- or trithymidine, site I and site II are occupied by
mononucleotides, site III is occupied by either two phosphates or a mononucleotide, and site V is occupied by a phosphate. Site IV is a
crystallographic binding site at the interface between three symmetry-related molecules and is not shown.
Bottom: A stereo close-up view of the ssDNA in the groove with a comparison of the apo T67-H365R structure (blue) and the complex (green).
The minor conformation of helix O is shown in hot pink. The structure of the wild-type N-terminal fragment in this region is identical to the
apo T67-H365R structure and is not shown.
oligonucleotide cleavage can still occur when using a of a cleavage-competent molecule, the covalent phos-
photyrosine intermediate of the cleavage reaction is ex-catalytically competent enzyme. Previously, it has been
observed that the 67 kDa N-terminal fragment can cata- pected to be transient, resulting in the release of the
product.lyze multiple rounds of cleavage either by making inter-
nal cuts at the preferred cleavage site or by sequentially The structure of the apo T67-H365R was solved to
high resolution to ensure that the mutant had essentiallyremoving one nucleotide from the 3 end until a minimal
oligonucleotide length (7 bases) has been reached (Lima the same structure as the wild-type protein (Table 1).
In fact, the structure of the apo T67-H365R enzyme iset al., 1993). For oligonucleotide cleavage, the expected
products are the minimal length nucleotide and single identical to the wild-type 67 kDa N-terminal fragment,
with an overall root-mean-square deviation (rmsd) ofnucleotides or short oligonucleotides 5 from the pre-
ferred cleavage site. There are six possible resulting 0.97 A˚ (0.45 A˚ for the main chain atoms and 1.3 A˚ for
the side chain atoms). No significant structural changesproducts from the oligonucleotide used in the experi-
ments. The most likely ones, based on previous observa- are present, confirming that the apo form of the mutant
can be used as a baseline for structural comparisons.tions (Lima et al., 1993) and the observed 7–8 bases
long product in the crystal, are 5-ACTTCGGG-3 and The conformation observed could be due to crystal
packing constraints imposed on the protein. However,5-ATG-3 from cleavage at one preferred cleavage site
or 5-ACTTCGGG-3 and three nucleotides, A, T, and G, the structure of a complex between E. coli topoisomer-
ase III and ssDNA, where a similar conformation wasdue to 3 end clipping. In addition, due to the presence
Structure
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Table 1. Data Collection and Refinement Statistics for H365 Mutants
Data Set T67-H365R T67-H365R/11
Data Collection
Detector type/source MAR-345/SSRL MAR-CCD/APS
Wavelength (A˚) 0.98 1.0
Space group P212121 P212121
Unit cell (A˚) a  63.0 a  63.4
b  78.7 b  79.1
c  139.3 c  141.8
Max. resolution (A˚) 1.67 1.9
Measured reflections 398,050 209,779
Unique reflections 79,717 53,723
Completeness (%)a 98.4 (98.4) 95.5 (66.4)
Rsym (%)a,b 5.1 (35.6) 6.1 (27.3)
Rmeas (%)a,c 5.7 (40.7) 6.9 (33.4)
Refinement
Resolution range 50–1.67 70–1.9
No. of reflections: working set/test set 75,619/4,024 52,986/2,749
R factor (%)d
Working set 20.5 22.4
Test set 22.7 27.2
Rmsd from ideality
Bond length (A˚) 0.005 0.013
Bond angles () 1.17 1.65
Average B factor (A˚2)e
Main chain 25.7 (7.1) 33.5 (11.2)
Side chains 30.3 (9.3) 36.3 (11.1)
Water molecules 40.6 (10.1) 48.4 (13.5)
DNA N/A 55.6 (13.6)
a Numbers in parentheses represent values in the highest resolution shell.
b Rsym  |I  I|/ I, where I  observed integrated intensity and I  average integrated intensity obtained from multiple measurements.
c As described in Diederichs and Karplus, 1997.
d R factor  |Fo| |Fc|/|Fo|, where |Fo|  observed structure factor amplitude and |Fc|  calculated structure factor amplitude.
e Numbers in parentheses represent rmsd.
observed (A. Changela, R.J. DiGate, and A.M., unpub- cleavage site. It could be either a single 5-TMP or the
T in the 5-ATG oligonucleotide. It has been observedlished data), lends support to the relevance of the topo-
isomerase I/ssDNA complex. Interestingly, the crystals previously that only one nucleotide in a 5-TTT oligonu-
cleotide is ordered and is undistinguishable from a 5-of the T67-H365R protein diffract to 1.7 A˚, a higher reso-
lution than the native crystals, even though arginine 365 TMP (Feinberg et al., 1999a); hence, it is not surprising
to observe a single ordered nucleotide. In the complex,is disordered and could not be positioned unambigu-
ously in the structure. a significant shift occurs in an  helix (helix O [Lima et
al., 1994]) in the DNA binding groove (Figure 2, bottom).The overall structure of the enzyme in the T67-H365R/
11 complex is very similar to the apo enzyme (Figure 2, Helix O contains many polar and positively charged resi-
dues that have re-aligned to create a ceiling of positivetop). Compared to the apo form of the mutant, the rmsd
for the main chain, side chain, and overall structure are charge against which the ssDNA phosphodiester back-
bone rests. In the structure, the helix exists in both a0.59 A˚, 1.27 A˚, and 0.99 A˚, respectively. The lack of
difference between the complex and the apo mutant major and minor conformation and is the only significant
structural change observed (Figure 2). Both the majorindicates that the protein is in the closed conformation.
In the structure of the complex, electron density can be and minor conformations of helix O in the presence of
ssDNA differ from its conformation in the apo form ofseen for 7 nucleotides. Six of the nucleotides are located
in the positively charged DNA binding groove extending the protein, with an rmsd of 1.82 A˚ and 2.69 A˚, respec-
tively, for all atoms.away from the active site with the 3 end facing the
catalytic tyrosine. This directionality is similar to the
one observed in the topoisomerase III/ssDNA complex DNA Binding and Conformation in the Complex
The ssDNA was modeled by testing the entire oligonu-(Changela et al., 2001). The seventh nucleotide corre-
sponds to a pyrimidine and is located near the active cleotide sequence against the available electron density
and examining the positive and negative Fo  Fc densitysite in the location previously designated as site I (Fein-
berg et al., 1999a) and was modeled as a 5-TMP (Figure in an omit map of the region. 5-pCTTCGGp-3was cho-
sen as the sequence that best fits the density. Although2). The presence of this nucleotide is likely to be the
result of oligonucleotide cleavage. Based on the possi- the 11-base oligonucleotide was synthesized with nei-
ther a 5- nor a 3-terminal phosphate, additional elec-ble cleavage products mentioned above, it is likely to
correspond to the T in the ATG sequence 5 of the tron density at the termini suggests dissimilar ends
E. coli Topoisomerase I/ssDNA Complex
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Figure 3. Oligonucleotide Binding in the DNA Binding Groove and near the Active Site
Top: Stereo diagram of the ssDNA located in the DNA binding groove. Bottom: The 5-TMP at a position adjacent to the active site (site I).
The ssDNA is shown in yellow, while topoisomerase I is shown with gray bonds and colored atoms. An omit map calculated without the TMP
or the ssDNA is shown at the 2.5	 level in cyan.
between the modeled DNA and the synthesized oligonu- ence of ssDNA and the minor conformation occurs in
the absence of ssDNA or is an intermediate form passingcleotide. It is possible that more than one sequence
may inhabit the groove, but the chosen sequence was between an empty binding groove and one bound to
DNA. As the minor conformation of the  helix does notconsidered to be the most likely based on the omit
map (Figure 3) and 32P-labeling of DNA from dissolved colocalize with the -helical path of the apo enzyme, it
is most likely an intermediate form between the boundcrystals of the complex.
Cleavage of the oligonucleotide at the preferred site and unbound DNA states. Alternatively, the minor con-
formation of the helix could correspond to the boundbetween Gua8 and Ade9 results in a 3-base fragment
with a 5 phosphate but not a 3 phosphate and an state and the major conformation to the intermediate
state. The observed occupancies of the two conforma-8-base fragment without a phosphate at either terminus.
Additionally, the ability to radiolabel the dissolved crys- tions and the B factors of the oligonucleotides make us
favor the first scenario, although it is not possible total suggests that the 5 end of the bound oligonucleotide
does not have a terminal phosphate. This suggests the rule out the alternative one.
The path of the oligonucleotide in the DNA bindingpresence of at least one additional, but disordered, nu-
cleotide at both the 5 and 3 ends, placing the cleavage groove follows a similar curve as one strand of B form
DNA with an overall rmsd of 1.9 A˚. The same phenome-site between Gua8 and Ade9. All these observations
strongly indicate that eight bases are present in the non is seen in the complex between topoisomerase III
and ssDNA (Changela et al., 2001) with an overall rmsdcomplex and that they correspond to the major cleavage
fragment. If the enzyme were to shift to the catalytically of 1.76 A˚ between the ssDNA in the two topoisomerase
complexes. Unlike the topoisomerase III/ssDNA com-competent conformation, the location of the preferred
cleavage site would be situated two bases 5 of the plex, the 3 end of the oligonucleotide does not enter
the active site. Instead, it curves toward His33, deviatingactive site tyrosine. Therefore, it is likely that the current
location of the oligonucleotide is due to maximization from the classic B form curve.
of protein-DNA contacts, as was observed in the topo-
isomerase III/ssDNA complex (Changela et al., 2001). Interactions between T67-H365R
and Single-Stranded DNAFurthermore, it appears that the binding groove limits
the maximal length of the oligonucleotide that can be The portion of the oligonucleotide located in the binding
groove is held into place by contacts between the phos-accommodated.
The B factors for the ssDNA are high compared to phate backbone and the surrounding residues as well
as the shifted helix in domain IV (Figure 4, top). Severalthe protein, greater than 56 A˚2 on average for the DNA
versus37 A˚2 for the protein, suggesting that the oligo- of the surrounding residues have moved to compensate
for the inclusion of ssDNA. As well-defined electron den-nucleotide does not fully occupy the binding groove.
The occupancy of the major conformation of helix O sity was not observed for the side chains of the minor
conformation of helix O, all the contacts refer to thesuggests that the major conformation exists in the pres-
Structure
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Figure 4. Diagram of Specific Hydrogen Bonds Made between the Oligonucleotide and the Protein in the DNA Binding Groove and at Site I
The coloring of the domains is the same as in Figure 2. Starting at the visible 5 end of the oligonucleotide, the nucleotides are Cyt2, Thy3,
Thy4, Cyt5, Gua6, and Gua7. Hydrogen bonds are shown as dashed lines.
Top: The shifted  helix has been made transparent, as it directly overlays the oligonucleotide and would prevent visualization of the bonds.
The ring stacking between Tyr177 and Thy3, as well as the stacking interaction between Cyt2 and Trp184, are shown.
Bottom: Superposition of the topoisomerase III/ssDNA complex on the T67-H365R/11 complex to show the location of the stacking tryptophans.
The topoisomerase III/ssDNA complex is colored blue: the protein is dark blue, the ssDNA is light blue, and Trp61 is light blue. The T67-
H365R protein is colored green, the ssDNA is in colors, and Trp184 is colored in magenta. The tryptophans are labeled in red, while the ssDNA
nucleotides are labeled in black. It can be seen that Trp61 in topoisomerase III comes in from a strand below the base of the 5 nucleotide
while Trp184 in topoisomerase I comes in from a helix above the base of the 5 nucleotide.
interactions between the major conformation and the A number of stacking interactions help stabilize the
ssDNA as well. The base of Thy3 stacks with the sideoligonucleotide. Starting at the 3 end of the nucleotide,
Arg507 has swung toward the phosphate of Thy3, while chain of Tyr177. The base of Cyt2 also stacks against the
indole ring of Trp184. Interestingly, a similar interactionGln197 and Ser192 have moved to contact the phos-
phate of Thy4. In fact, in the apo form, Gln197 would occurs between Trp61 and Cyt1 in the topoisomerase
III/ssDNA complex. Though Trp61 in topoisomerase III isbe located in the same spot as the phosphate for Cyt5.
Instead, in the complex, Gln197 contacts the phosphate not sequentially equivalent to Trp184 in topoisomerase I,
the two tryptophans are spatially close and serve thefor both Thy4 and Cyt5. Thr496 does not move, but
makes contact with the phosphate of Gua6. An invariant same function in the complex (Figure 4, bottom). Trp61
in topoisomerase III extends from a loop to contact thearginine, Arg321, blocks the oligonucleotide from con-
tact with Tyr319, the active site tyrosine, while making a 8-base oligomer in the topoisomerase III binding groove
from the bottom, while Trp184 in topoisomerase I con-contact with the phosphate of Gua7. His33 also contacts
the phosphate of Gua7. All of these phosphate-con- tacts the oligonucleotide in topoisomerase I from the
top of the groove. An analogous tryptophan, 703, existstacting residues are highly conserved. The only se-
quence-specific contact between a side chain and the at a similar position in the crystal structure of Archaeo-
globus fulgidus reverse gyrase (Rodriguez and Stock,oligonucleotide occurs between a partially conserved
residue, Arg169, and the O2 of Thy4. While helix O does 2002) and corresponds sequentially to Trp184. Se-
quence alignment of 34 type IA topoisomerases alsonot make direct contacts with the ssDNA, it does form
a positively charged patch along the phosphodiester shows that the majority of type IA enzymes can be di-
vided into two groups with regards to partial conserva-backbone. The lack of specific contacts between the
bases and the protein shows how helix O may provide tion of a tryptophan in this region (Figure 5). Fourteen
type IA topoisomerases, with a higher sequence similar-topoisomerase I with the flexibility to interact with many
different DNA sequences. ity to E. coli topoisomerase I, have a tryptophan corre-
E. coli Topoisomerase I/ssDNA Complex
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Figure 5. Multiple Sequence Alignment of Type IA Topoisomerases Based on the Structural Alignment of E. coli DNA Topoisomerase I, E.
coli DNA Topoisomerase III, and A. fulgidus Reverse Gyrase
The sequences were initially aligned using BESTFIT (GCG, 1997), and then adjustments were made using a text editor based on the structure
alignment of E. coli DNA topoisomerase I, E. coli DNA topoisomerase III, and A. fulgidus reverse gyrase. Final shading of the alignment was
performed using the BoxShade server (http://www.ch.embnet.org/software/BOX_form.html). Identical residues have white text on a black
background. Similar residues have black text on a gray background; other residues have black text on a white background. The conserved
tryptophans are shown in red and marked by a red box across the sequences. The name of the enzymes classified as topoisomerase I are
shaded in blue, while the ones classified as topoisomerases III are shown in pink. Only the sequence segments pertaining to the conserved
tryptophans are shown. Identity of sequences are as follows: TOP1_ECOLI, Escherichia coli DNA Topoisomerase I; TOP1_HAEIN, Haemophilus
influenzae DNA Topoisomerase I; TOP1_BACSU, Bacillus subtilis DNA Topoisomerase I; TOP1_TREPA, Treponema pallidum DNA Topoisomer-
ase I; TOP1_FERIS, Fervidobacterium islandicum DNA Topoisomerase I; TOP1_THEMA, Thermotoga maritima DNA Topoisomerase I;
TOP1_HELPJ, Helicobacter pylori J99 DNA Topoisomerase I; TOP1_HELPY, Helicobacter pylori DNA Topoisomerase I; TOP1_MYCLE, Mycobac-
terium leprae DNA Topoisomerase I; TOP1_MYCTU, Mycobacterium tuberculosis DNA Topoisomerase I; TOP1_STRCO, Streptomyces coelico-
lor DNA Topoisomerase I; TOP1_SYNP7, Synechococcus sp. (strain PCC 7942) (Anacystis nidulans R2) DNA Topoisomerae I; TOP1_SYNY3,
Synechocystis sp. (strain PCC 6803) DNA Topoisomerase I; TOP1_MYCGE, Mycoplasma genitalium DNA Topoisomerase I; TOP1_MYCPN,
Mycoplasma pneumoniae DNA Topoisomerase I; TOP3_ECOLI, Escherichia coli DNA Topoisomerase III; TOP3_HAEIN, Haemophilus influenzae
DNA Topoisomerase III; TP3A_HUMAN, Homo sapiens DNA Topoisomerase III ; TP3A_MOUSE, Mus musculus DNA Topoisomerase III
; TOP3_CAEEL, Caenorhabditis elegans DNA Topoisomerase III; TOP3_SCHPO, Schizosaccharomyces pombe DNA Topoisomerase III;
TOP3_YEAST, Saccharomyces cerevisiae DNA Topoisomerase III; TP3B_HUMAN, Homo sapiens DNA Topoisomerase III 
-1; TP3B_MOUSE,
Mus musculus DNA Topoisomerase III 
-1; TOP3_DROME, Drosophila melanogaster DNA Topoisomerase III; TOP1_AQUAE, Aquifex aeolicus
DNA Topoisomerase I; TOP1_BORBU, Borrelia burgdorferi DNA Topoisomerase I; TOP1_RICPR, Rickettsia prowazekii DNA Topoisomerase
I; TOPG_SULAC, Sulfolobus acidocaldarius Reverse Gyrase; 1GKU, Archaeoglobus fulgidus Reverse Gyrase; TOP1_BACFI, Bacillus firmus
DNA Topoisomerase I; TOP1_BACAN, Bacillus anthracis DNA Topoisomerase I.
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sponding to the location of Trp184, while sixteen en- Biological Implications
zymes have a tryptophan corresponding to Trp61 in E. The mechanism of many enzymes requires going
coli topoisomerase III. Four enzymes have tryptophans through a series of large conformational changes during
at both positions, but it is not clear that both tryptophans catalysis. Some of the intermediate conformations are
play similar roles. Finally, of the 34, only 4 type IA en- by nature unstable. Topoisomerases represent a class
zymes are unaccounted for: Bacillus anthracis, Bacillus of enzymes that need to alter their conformation in a
firmus, Helicobacter pylori, and Helicobacter pylori J99. dramatic way in order to change the topology of DNA.
The fact that stacking occurs between a tryptophan and Type IA topoisomerases have been extensively studied,
the nucleotide base and that the interactions are seen and a detailed mechanism of action has been postulated
both in topoisomerase I and topoisomerase III in com- that is supported by existing biochemical, biophysical,
plex with ssDNA, along with partial conservation of this and structural data (Brown and Cozzarelli, 1981;
tryptophan in two locations, suggests that this interac- Changela et al., 2001; Dekker et al., 2002; Feinberg et
tion may be necessary for stabilizing the DNA in the al., 1999b; Li et al., 2001). Nevertheless, knowledge of
groove and is not a crystallographic artifact. the structure of additional conformational stages in the
Previous biochemical studies in which His365 was cycle is needed in order to understand in atomic detail
replaced by an arginine showed that His365 plays a role the way these enzymes recognize, bind, cleave, and
in binding DNA, but it was unclear whether the effect is religate DNA, and also the conformational changes that
direct or indirect (Perry and Mondrago´n, 2002). In the occur during these processes. To date, the structure of
presence or absence of DNA, the T67-H365R structures three type IA topoisomerases in the absence of DNA are
do not show additional ordering of the loop between known: E. coli topoisomerases I and III and A. fulgidus
amino acids 356 and 364. Therefore, it is unlikely that reverse gyrase. In all three cases, the structure is in the
His365 modifies the flexibility of this loop, nor, conse- closed conformation, suggesting that, in the absence
quently, access to the active site tyrosine through orien- of DNA, this conformation is the most stable form of
tation of this disordered loop. Unlike the structure of the protein. The only previous structure of a type IA
the apo H365R mutant where the arginine is disordered, topoisomerase in the presence of DNA is that of an
in the complex, Arg365 is 4 A˚ distant from the phos- inactive E. coli topoisomerase III. In this case, the struc-
phate of the nucleotide at site I, contacts the sugar of ture is in a partially open conformation, showing that
the nucleotide, and has well-defined electron density. the protein must change conformation to accommodate
In fact, three arginines, 114, 161, and 365, come into
the DNA and to form the active site.
the immediate vicinity of this phosphate. In the complex,
The structure presented herein shows a third confor-
as in the structure of either T67 or T67-H365R in complex
mation for a type IA topoisomerase and a second confor-with 5-TTT (Feinberg et al., 1999a; Perry, 2002), the
mation for an enzyme/ssDNA complex. The structurethree residues form a positively charged pocket around
appears to correspond to an intermediate conformationthe phosphate. Both His365 and Arg114 are conserved
between the closed state and the catalytically compe-and, coupled with earlier biochemical studies (Perry and
tent state; it may represent a structural link betweenMondrago´n, 2002), this suggests that while His365 is
two stages in the reaction cycle (stage b**, Figure 1).too far away to contact a nucleotide directly, it may still
As the religation reaction is probably the reverse of theaid in attracting DNA to the active site by participating
cleavage reaction, it is difficult to ascertain whether thein creating a positively charged electrostatic environ-
complex corresponds to a precleavage (stage b**, Fig-ment, as previously proposed (Perry and Mondrago´n,
ure 1) or to a postligation (stage h**, Figure 1) structure;2002).
instead, it is very likely that the complex is representativeThe location of ssDNA in the T67-H365R/11 complex
of both stages. Furthermore, as in the complex struc-does not coincide with any of the location of nucleotides
ture, the protein is in the closed conformation and oligo-seen in the structures of wild-type and apo mutant en-
nucleotide cleavage has occurred; this suggests thatzymes in the presence of nucleotides (Feinberg et al.,
one of the conformations of helix O may represent the1999a; Perry, 2002). In the complex structure, site II and
enzyme beginning to open to allow ssDNA to bind (asite III are devoid of nucleotides, though site III contains
state between stages a* and b** in Figure 1), while thea sulfate ion (Figure 2). Site V is occupied by a sulfate
other conformation may represent the enzyme in a moreion in both the apo and complex structures, and it is
advanced state in the process (stage b**, Figure 1). Simi-likely that it was previously misidentified. Yet, in the
larly, one conformation may represent the enzyme afterabsence of DNA, the apo structure shows site I occupied
the ssDNA has been ejected from the binding grooveby two sulfate ions. Thus, nonspecific binding of nucleo-
(a state between stages h** and i* in Figure 1), andtides to topoisomerase I, as seen in the complexes be-
the other conformation could show the postcleavagetween wild-type enzyme (Feinberg et al., 1999a) or the
enzyme prior to DNA release (stage h**, Figure 1).H365R mutant and nucleotides (Perry, 2002), occurs at
The accommodation of eight nucleotides via smallsite II and site III in the hole of the toroid. On the other
local movements and a helix shift in domain IV in thishand, when the enzyme binds longer and more specific
complex, compared to the large rearrangements of thesequences, as in this complex between T67-H365R and
main body of the enzyme observed in the topoisomerasean 11-mer containing a preferred cleavage site, only site
III complex, suggests that the temporal changes duringI and the DNA binding groove are occupied. Nonspecific
the reaction follow the observed structures. (1) In thebinding may be utilized by the enzyme for holding the
absence of DNA, the protein is in the closed conforma-passing strand, whereas more specific DNA binding
tion without exposing the active site tyrosine or formingmust occur in order to orient the DNA at the cleavage
site. the active site (stages a* or i* in Figure 1). (2) The enzyme
E. coli Topoisomerase I/ssDNA Complex
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quential macroseeding (Stura and Wilson, 1990, 1991) into unequili-first recognizes and interacts with ssDNA by accepting
brated hanging drops containing topoisomerase I and ssDNA (1:1it into the binding groove with minimal conformational
ratio), 2.2 M (NH4)2SO4, 0.1 M Na acetate (pH 5.0).changes aside from the movement of one helix. During
this stage, the ssDNA starts to adopt a B-DNA-like con-
Data Collection, Processing, and Refinement
formation that complements the binding groove (stages Crystals of apo T67-H365R were harvested, slowly transferred in
b** and h**, Figure 1). (3) Once ssDNA is in the groove, 3% steps (2 min/step) into a cryosolution (25% sucrose, 2.8 M
(NH4)2SO4), mounted within a rayon loop, and then flash frozen inthe enzyme continues with the conformational changes,
liquid nitrogen. T67-H365R/11 crystals were harvested, transferredpossibly triggered by the movement of the helix, and
directly into a 25% sucrose, 2.2 M (NH4)2SO4, 0.1 M Na acetate (pHopens up the active site. Concomitant with this protein
5.0) solution, mounted on a rayon loop, and then flash frozen inconformational change, the ssDNA changes conforma-
liquid nitrogen.
tion to enter the active site (stages c* and f*, Figure T67-H365R data were collected at the SSRL, processed with
1). The transition from the closed conformation to the DENZO (Otwinowski and Minor, 1997), and merged with SCALA
(CCP4, 1994). The structure was solved using the native structurecatalytically competent conformation probably involves
(Lima et al., 1994) as a model. Refinement was performed with CNSmany more states, and the currently available structures
(Brunger et al., 1998) and consisted of rigid body, positional, and Bare starting to illuminate the nature of the changes and
factor refinement. Based on the shape of the electron density, ninethe sequence of the events. It is particularly interesting
peaks greater than 5	 were modeled as sulfates. Some of these
to note that it appears that ssDNA can bind the protein peaks were previously modeled as water molecules. Due to the
without triggering the opening of the active site. It may higher resolution, 27 alternate side chain conformations were visible.
Secondary side chain conformations were added based on positivebe that only when the correct type of DNA is recognized,
Fo  Fc density greater than 3	. After model adjustment, CNS wasi.e., ssDNA exceeding a minimal length, does the full
used to add waters to peaks in the Fo  Fc electron density mapsconformational change occur.
greater than 2.5	 and within hydrogen bonding distance. The modelIn conclusion, the structure of E. coli topoisomerase
was re-inspected for changes after bulk solvent corrections and
I in complex with ssDNA represents a new conformation CNS was used to refine the alternate conformations.
for a type IA topoisomerase that may represent the initial In the 67 kDa N-terminal fragment, clear electron density is present
for residues 2–38, 62–356, 365–441, and 448–590. In the final struc-step in ssDNA recognition or the final state before
ture of the arginine mutant, there are two additional ordered residuesssDNA is released. It shows a conformational state that
in the C terminus of the fragment. One additional residue (39) isis an intermediate between the empty enzyme in the
visible in the disordered region between amino acids 38 and 62,closed conformation and the enzyme in a more open
and two additional residues (446–447) are visible in the disordered
conformation with a catalytically competent, ssDNA- region between amino acids 441 and 448. Amino acids 62–64 were
occupied active site. Interestingly, it indicates that the completely rebuilt, resulting in removal of amino acid 62. There are
9 sulfates and 576 waters in the final structure.enzyme can first recognize and bind ssDNA with very
Two data sets for T67-H365R complexed with the 11-base oligo-small structural distortions before changing conforma-
nucleotide were collected at DND-CAT at the APS, integrated withtion more dramatically to create the active site, accept
XDS (Kabsch, 1993), and scaled and merged with SCALA (CCP4,the ssDNA, and cleave the phosphodiester backbone.
1994). The structure was solved using the native structure (Lima et
This new conformation was unanticipated; it was ex- al., 1994) as a model. Initial refinement was performed with CNS
pected that ssDNA binding would always cause a transi- (Brunger et al., 1998) and consisted of rigid body, positional, and B
factor refinement. After initial model adjustment and building of thetion to the fully formed, catalytically competent confor-
DNA in the complex, waters were added using ARP/wARP (Lamzinmation, as seen in the complex between E. coli
and Wilson, 1993) in Refmac5 (Murshudov et al., 1997).topoisomerase III and ssDNA. Additionally, the structure
In the structure of the complex, one additional residue (serine 40)supports the involvement of the invariant His365 in
can be seen in the disordered region between amino acids 39 and
ssDNA binding and the limit of 8 nucleotides in the bind- 63. Two additional amino acids are visible in the disordered loop
ing groove and shows the necessity of a stabilizing tryp- near site I, residues 357 and 364. Residue 441 was removed from
the structure. There are five alternate side chain conformations intophan interacting with the 5 end of the ssDNA. More
the structure that were modeled at 50% occupancy each. The majorimportantly, the structures of several conformational
conformation of helix O—residues 499 to 507—was modeled atstates are beginning to provide an atomic picture of the
67% occupancy while the minor conformation was modeled at 33%different intermediates undertaken by both protein and
occupancy. The side chains of the minor conformation are not visi-
DNA during the complex process of DNA relaxation by ble, but a second conformation is indicated by the presence of
type IA topoisomerases. positive Fo  Fc density for the main chain above 3.5	 when only a
single conformation is modeled. Alternate conformations for side
chains and the  helix located in the DNA binding groove wereExperimental Procedures
refined using Refmac5. The final structure has 5 sulfates and 561
waters.Purification and Crystallization
Inspection of 2Fo  Fc and Fo  Fc density maps and modelT67-H365R protein was purified to homogeneity as previously
rebuilding were performed using the graphics program O (Jones etdescribed (Lima et al., 1993; Perry and Mondrago´n, 2002). The 11-
al., 1991). Data collection and refinement statistics are summarizedbase oligomer, 5-ACTTCGGGATG-3, was purchased from Inte-
in Table 1. Figures were made with PyMOL (DeLano, 2002), MOL-grated DNA Technologies and purified by reverse phase HPLC
SCRIPT (Kraulis, 1991), and RASTER3D (Merritt and Murphy, 1994).(Aggarwal, 1990). A factorial screen was used to determine crystalli-
zation conditions for both the apo enzyme and the complex. T67-
H365R crystallized in conditions similar to the wild-type fragment. 5 End Labeling
Crystals of the complex were sequentially washed in 2.8 MDiffraction-quality crystals were obtained by hanging drop vapor
diffusion and dialysis as previously described (Lima et al., 1993) (NH4)2SO4, then dissolved in distilled water. The dissolved crystals
were radioactively labeled as previously described (Perry, 2002) andwith optimization of the (NH4)2SO4 concentration. Poorly formed
crystals of a complex of T67-H365R and the 11-mer (T67-H365R/ examined by electrophoresis on a 19:1 polyacrylamide gel con-
taining 50% w/v urea in 1 TBE. Radiolabeled uncut oligonucleo-11) mixed at a 1:1 ratio were initially detected in 2.1 M (NH4)2SO4.
Diffraction-quality crystals of the complex were generated by se- tides of 11, 8, and 7 bases in length, and [-32P]ATP were used as
Structure
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molecular weight standards. The gel was autoradiographed on a maps and the location of errors in these models. Acta Crystallogr.
A 47, 110–119.Packard InstantImager.
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